IXALTIS
Pre-clinical3 clinical compounds licensed from Sanofi kick start the development of the company.
Founded
2012
Focus
Small Molecules
About
3 clinical compounds licensed from Sanofi kick start the development of the company.
Funding History
2Total raised: $40M
Series B$25MSofinnova PartnersMar 15, 2019
Series A$15MSofinnova PartnersSep 15, 2016
Company Info
TypePrivate
Founded2012
LocationLyon, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile